Watson Pharmaceuticals’ TRELSTAR receives FDA approval for treatment of advanced prostate cancer
March 15, 2010 by Prostate Dr. · Comments Off
Multimedia software program developed to help prostate cancer patients make treatment decisions
Mount Sinai School of Medicine is leading a study of patients newly-diagnosed with prostate cancer to determine if providing them with multimedia materials can help them make more informed treatment decisions. Michael Diefenbach, Ph.D., Associate Professor of Urology at Mount Sinai School of Medicine developed a multimedia software program designed to help prostate cancer patients and their …
Read more…
»»Read more: Watson Pharmaceuticals’ TRELSTAR receives FDA approval for treatment of advanced prostate cancer